doi: 10.1136/pgmj.50.580.125.
Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation
- PMID: 4465774
- PMCID: PMC2495487
- DOI: 10.1136/pgmj.50.580.125
Item in Clipboard
Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation
Postgrad Med J.
1974 Feb.
Abstract
Unless the equivalence of different products has been established, the prescriber must define the product he requires by using the trade name. Present pharmacopoeial standards based on in vitro methods are inadequate to predict equivalence in man. There are many ways in which differences in formulation may influence absorption of drugs, and only comparable absorption profiles can be taken as evidence of equivalence.
Similar articles
-
Trade names or approved names. Point II. Points of view. The clinical pharmacologist.Postgrad Med J. 1974 Feb;50(580):93-5. doi: 10.1136/pgmj.50.580.93. Postgrad Med J. 1974. PMID: 4465784 Free PMC article.
-
Trade names or approved names. Part III. Special cases. The digoxin affair.Postgrad Med J. 1974 Feb;50(580):98-102. doi: 10.1136/pgmj.50.580.98. Postgrad Med J. 1974. PMID: 4465786 Free PMC article.
-
Trade names or approved names. Part IV. The solution. Introduction.Postgrad Med J. 1974 Feb;50(580):121. doi: 10.1136/pgmj.50.580.121. Postgrad Med J. 1974. PMID: 4465772 Free PMC article. No abstract available.
-
Drugs, drug products and prescribing habits.Drugs. 1971;2(5):447-53. doi: 10.2165/00003495-197102050-00003. Drugs. 1971. PMID: 4948544 Review. No abstract available.
-
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.Int J Pharm. 2011 Nov 25;420(1):1-10. doi: 10.1016/j.ijpharm.2011.08.032. Epub 2011 Aug 30. Int J Pharm. 2011. PMID: 21884771 Review.
